BRIDGEWATER, N.J., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced the U.S. commercial launch of Brekiya® (dihydroergotamine ...
Migraines are a type of headache that affects up to 12% of adults, according to Carlos Azaret, M.D., a neurologist affiliated with HCA Florida Woodmont Hospital in Tamarac, Florida. As a subclass of ...
MAPLE GROVE, Minn., June 26, 2023 /PRNewswire/ -- Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it has entered into a definitive agreement under which New Jersey-based Tonix ...
Brekiya ® autoinjector, a new specialty therapy from Amneal, is now available for prescription exclusively through Walgreens Specialty Pharmacy and Sterling Specialty Pharmacy BRIDGEWATER, N.J., Oct.